Fig. 3: Overview of the sample characteristics for the 100,000 Genomes Cancer Programme cohort.

Breakdown according to the stage of the disease (left) (NA, not available or not applicable in the context of glioblastoma multiforme and low-grade glioma), type of sample obtained (middle) and tumor purity (right) for each tumor type; the IQR and median values are shown.